Low vitamin D levels affect drug efficacy in HCV patients

12/20/2009 | Medscape (free registration)

An Italian study showed hepatitis C patients have lower serum levels of 25-hydroxyvitamin D than people without the virus, which affects treatment efficacy. The study showed that as vitamin D levels decline, so do the chances that a patient with chronic HCV will have a sustained response to interferon and ribavirin.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN